The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel ...

Veteran scientist Hideo Makimura, M.D., Ph.D., is going fully preclinical by joining gene therapy biotech Affinia ...

AstraZeneca’s AZN fourth-quarter 2024 core earnings of $1.05 per American depositary share (“ADS”) missed the Zacks Consensus ...

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

For the first time, the FDA will consider whether to approve a trio of drugs for tiny patient populations based on trials ...

Algiax Pharmaceuticals’ non-opioid candidate has achieved “clinically meaningful” pain reduction in a mid-stage trial of ...

AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq ...

Clinical trials demonstrated that a single dose of Symbravo provides rapid migraine relief, sustains efficacy for up to 48 ...

The Space Force must balance its main responsibility of ensuring national security with the goal of supporting a competitive commercial space sector. Panzenhagen stated while its top priority is ...

Mark Genovese, MD, senior vice president at Lilly Immunology Development, spoke with Pharmaceutical Executive about the importance of developing medicines that treat disruptive symptoms of chronic ...

The comments mark the latest in a number of trade-related threats unleashed ... home of major drugmakers such as Takeda, Astellas, Daiichi Sankyo and Eisai, which has been expecting strong sales ...

The comments mark the latest in a number of trade-related threats unleashed ... home of major drugmakers such as Takeda, ...